Showing results (91-100 of 382) with videos related to
Sort By:
Pageof 39
Haematologica|August 2, 2007
Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survivalStephan Stilgenbauer, Sandrine Sander, Lars Bullinger, et al.International Journal of Cancer|June 23, 2015
Targeting inhibitor of apoptosis proteins by Smac mimetic elicits cell death in poor prognostic subgroups of chronic lymphocytic leukemiaDaniela Opel, Andrea Schnaiter, Dagmar Dodier, et al.Cancer Immunology, Immunotherapy : CII|August 10, 2022
Immune phenotypes and checkpoint molecule expression of clonally expanded lymph node-infiltrating T cells in classical Hodgkin lymphomaAlexej Ballhausen, Amin Ben Hamza, Carlotta Welters, et al.Scientific Reports|October 26, 2022
Widely applicable, extended flow cytometric stem cell enumeration panel for quality control of advanced cellular productsKaty Haussmann, Mathias Streitz, Anna Takvorian, et al.Epigenetics|May 29, 2014
Differential methylation in CN-AML preferentially targets non-CGI regions and is dictated by DNMT3A mutational status and associated with predominant hypomethylation of HOX genesYing Qu, Andreas Lennartsson, Verena I Gaidzik, et al.Leukemia Research|November 1, 2024
In vitro testing of drug response in primary multiple myeloma cells using a microwell-based technologyJosefine Krüger, Igor Wolfgang Blau, Olga Blau, et al.Blood|December 23, 2016
Cancer-specific changes in DNA methylation reveal aberrant silencing and activation of enhancers in leukemiaYing Qu, Lee Siggens, Lina Cordeddu, et al.Leukemia & Lymphoma|May 31, 2018
AML: high serum ferritin at initial diagnosis has a negative impact on long-term survivalJana Ihlow, Sophia Gross, Annabel Sick, et al.Cancers|September 12, 2018
miR-9-5p in Nephrectomy Specimens is a Potential Predictor of Primary Resistance to First-Line Treatment with Tyrosine Kinase Inhibitors in Patients with Metastatic Renal Cell CarcinomaBernhard Ralla, Jonas Busch, Anne Flörcken, et al.Oncotarget|June 2, 2018
MYB induces the expression of the oncogenic corepressor SKI in acute myeloid leukemiaMiriam Frech, Sabine Teichler, Christine Feld, et al.Pageof 39